Mitra-Sadat Sadat-Shirazi

Dr. Mitra-Sadat Sadat-Shirazi

Tufts Medical Center, Boston, Massachusetts, USA
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Peptides
Verified
Journal Article
Closed access
HAHamid Ahmadian-Moghadam
Hamid Ahmadian-Moghadam
MSMitra-Sadat Sadat-Shirazi
Mitra-Sadat Sadat-Shirazi
MZMohammad Reza Zarrindast
Mohammad Reza Zarrindast

1 September 2019 in Nature and Science of Sleep
Verified
Journal Article
Open access
PDF file
SMSarah Mahboubi
Sarah Mahboubi
MNMohammad Nasehi
Mohammad Nasehi
AIAlireza Imani
Alireza Imani
MSMitra-Sadat Sadat-Shirazi
Mitra-Sadat Sadat-Shirazi
MZMohammad-Reza Zarrindast
Mohammad-Reza Zarrindast
MNMaryam Noroozian
Maryam Noroozian
Background: Many factors affect our learning and memory quality, but according to different studies, having a positive or negative impact pertains to their characteristics like intensity or the amount. Purpose: The present study was conducted to investigate the effect of 24-hour REM-sleep deprivation on continuous-high intensity forced exercise-induced memory impairment and its effect on Brain-Derived Neurotrophic Factor (BDNF) and Tyrosine kinase B (TrkB) levels in the hippocampus and Prefrontal Cortex area (PFC). Material and methods: Animals were conditioned to run on treadmills for 5 weeks then, were deprived of sleep for 24 h using the modified multiple platforms. The effect of intensive exercise and/or 24-h REM-SD was studied on behavioral performance using Morris Water Maze protocol for 2 days, and BDNF/TrkB levels were assessed in hippocampus and PFC after behavioral probe test using western blotting. Results: After 5 weeks of intensive exercise and 24-h REM-SD, spatial memory impairment and reduction of BDNF and TrkB levels were found in hippocampus and PFC. 24-h REM-SD improved memory impairment and intensive exercise-induced downregulation of BDNF and TrkB protein levels. Conclusion: The results of the study suggested that sleep deprivation might act as a compensatory factor to reduce memory impairment when the animal is under severe stressful condition.

1 February 2018 in Physiology & Behavior
Verified
Journal Article
Closed access
AAArdeshir Akbarabadi
Ardeshir Akbarabadi
SNSaba Niknamfar
Saba Niknamfar
NVNasim Vousooghi
Nasim Vousooghi
MSMitra-Sadat Sadat-Shirazi
Mitra-Sadat Sadat-Shirazi
HTHeidar Toolee
Heidar Toolee
MZMohammad Reza Zarrindast
Mohammad Reza Zarrindast

27 April 2020 in Biotechnology Letters
Verified
Journal Article
Closed access
PDF file
HAHamid Ahmadian-Moghadam
Hamid Ahmadian-Moghadam
MSMitra-Sadat Sadat-Shirazi
Mitra-Sadat Sadat-Shirazi
MZMohammad Reza Zarrindast
Mohammad Reza Zarrindast

4 August 2010 in Journal of Psychopharmacology
Verified
Journal Article
Closed access
PDF file
MZMohammad Reza Zarrindast
Mohammad Reza Zarrindast
SMSara Mahboobi
Sara Mahboobi
MSMitra-Sadat Sadat-Shirazi
Mitra-Sadat Sadat-Shirazi
SAShamseddin Ahmadi
Shamseddin Ahmadi
In the present study the influence of the dopaminergic system(s) of the amygdala on the anxiolytic-like effect of the cannabinoid CB1 receptor agonist, arachydonilcyclopropylamide (ACPA), in male Wistar rats was investigated. An elevated plus-maze test of anxiety was used to assess anxiety-like behaviors. The results showed that bilateral intra-amygdala injections of ACPA (0.125, 1.25 and 5 ng/rat) and the mixed dopamine D1/D2 receptor agonist, apomorphine, at different doses (0.001, 0.01 and 0.1 µg/rat) increased percentage open arm time (%OAT) and percentage open arm entries (%OAE), indicating an anxiolytic-like effect for both of the drugs. In contrast, intra-amygdala administration of the dopamine D1 receptor antagonist SCH23390 (0.5 and 1 µg/rat) and the dopamine D2 receptor antagonist, sulpiride (2 and 3 µg/rat) decreased %OAT and %OAE, suggesting an anxiogenic-like effect for both of the drugs. Interestingly, pretreatment with a sub-effective dose of apomorphine (0.0005 µg/rat) increased, while SCH23390 (0.25 µg/rat) and sulpiride (1.5 µg/rat) decreased the anxiolytic-like effect of ACPA. It can be concluded that the dopaminergic system of the amygdala may be involved, at least partly, in the anxiolytic-like effects induced by ACPA in the rat amygdala.

1 May 2018 in The Journal of Pain
Verified
Journal Article
Closed access
GAGhorbangol Ashabi
Ghorbangol Ashabi
MSMitra-Sadat Sadat-Shirazi
Mitra-Sadat Sadat-Shirazi
AAArdeshir Akbarabadi
Ardeshir Akbarabadi
NVNasim Vousooghi
Nasim Vousooghi
ZKZahra Kheiri
Zahra Kheiri
MZMohammad Reza Zarrindast
Mohammad Reza Zarrindast